{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:14:54Z","timestamp":1791389694179,"version":"4.3.3"},"reference-count":56,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"3","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introducci\u00f3n. Los datos sobre la prevalencia de coinfecciones o sobreinfecciones f\u00fangicas en pacientes con COVID-19 son limitados.Objetivo. Describir la prevalencia de coinfecciones o sobreinfecciones f\u00fangicas en pacientes con COVID-19, as\u00ed como los factores de riesgo y las caracter\u00edsticas demogr\u00e1ficas, cl\u00ednicas y microbiol\u00f3gicas.Material y m\u00e9todos. Se incluyeron pacientes con diagn\u00f3stico confirmado de COVID-19, hospitalizados en la unidad de cuidados intensivos y con infecci\u00f3n f\u00fangica confirmada entre marzo del 2020 y diciembre del 2021. Del expediente cl\u00ednico se obtuvieron datos sobre edad, sexo, comorbilidades, d\u00edas de estancia hospitalaria, resultados de laboratorio (ferritina) y microbiol\u00f3gicos, tratamiento contra COVID-19, terapia antif\u00fangica y desenlace.Resultados. Once de 740 pacientes cumplieron con los criterios de inclusi\u00f3n. La tasa de coinfecci\u00f3n fue del 0,3 % y la de sobreinfecci\u00f3n fue del 1,2 %. La poblaci\u00f3n m\u00e1s afectada fue la de hombres adultos. Las coinfecciones o sobreinfecciones diagnosticadas fueron candiduria y candidemia, causadas por Candida albicans, C. tropicalis, C. glabrata, C. lusitaniae y Kluyveromyces marxianus (C. kefyr). Adem\u00e1s, se encontr\u00f3 una traqueobronquitis por Aspergillus fumigatus. Los antif\u00fangicos m\u00e1s administrados fueron fluconazol y caspofungina. La letalidad en pacientes con coinfecciones fue del 50 % y con sobreinfecciones f\u00fangicas, del 22 %. El tiempo de estancia intrahospitalaria fue de 11 a 65 d\u00edas. Ocho de los pacientes requirieron asistencia respiratoria mec\u00e1nica y seis recibieron corticoides. La principal comorbilidad fue diabetes mellitus (81,8 %).Conclusiones. La tasa de coinfecciones o sobreinfecciones por hongos en pacientes con COVID-19 fue baja, pero la letalidad de estas requiere, con urgencia, la realizaci\u00f3n de pruebas de rutina para detectar hongos en pacientes con COVID-19 grave para diagnosticar oportunamente infecciones f\u00fangicas que puedan comprometer a\u00fan m\u00e1s la vida del paciente<\/jats:p>","DOI":"10.7705\/biomedica.7251","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T12:55:07Z","timestamp":1725540907000},"page":"328-339","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":4,"title":["Coinfecci\u00f3n o sobreinfecci\u00f3n f\u00fangica en pacientes con COVID-19 en un hospital de tercer nivel en M\u00e9xico","Fungal coinfection\/superinfection in COVID-19 patients in a tertiary hospital in Mexico"],"prefix":"10.7705","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-9380","authenticated-orcid":false,"given":"Eduardo","family":"Garc\u00eda-Salazar","sequence":"first","affiliation":[{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0766-843X","authenticated-orcid":false,"given":"Sandra","family":"Benavidez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-3317","authenticated-orcid":false,"given":"Alexandro","family":"Bonifaz","sequence":"additional","affiliation":[{"name":"Laboratorio de Micolog\u00eda, Servicio de Dermatolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Laboratorio de Micolog\u00eda, Servicio de Dermatolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0909-1938","authenticated-orcid":false,"given":"Emma Alejandra","family":"Hern\u00e1ndez-Mendoza","sequence":"additional","affiliation":[{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7348-6615","authenticated-orcid":false,"given":"X\u00f3chitl","family":"Ram\u00edrez-Maga\u00f1a","sequence":"additional","affiliation":[{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3866-9995","authenticated-orcid":false,"given":"Mar\u00eda del Roc\u00edo","family":"Reyes-Montes","sequence":"additional","affiliation":[{"name":"Laboratorio de Micolog\u00eda, Servicio de Dermatolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico; Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Laboratorio de Micolog\u00eda, Servicio de Dermatolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico; Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6315-7860","authenticated-orcid":false,"given":"Esperanza","family":"Duarte-Escalante","sequence":"additional","affiliation":[{"name":"Laboratorio de Micolog\u00eda, Servicio de Dermatolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico; Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Laboratorio de Micolog\u00eda, Servicio de Dermatolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico; Departamento de Microbiolog\u00eda y Parasitolog\u00eda, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5623-6683","authenticated-orcid":false,"given":"Gustavo","family":"Acosta-Altamirano","sequence":"additional","affiliation":[{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-8698","authenticated-orcid":false,"given":"Mar\u00eda Guadalupe","family":"Fr\u00edas-De-Le\u00f3n","sequence":"additional","affiliation":[{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Hospital Regional de Alta Especialidad Ixtapaluca, IMSS-BIENESTAR, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"137619","doi-asserted-by":"crossref","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: A systematic review and meta-analysis. J Infect. 2020;81:26675. https:\/\/doi.org\/10.1016\/j.jinf.2020.05.046","DOI":"10.2139\/ssrn.3594598"},{"key":"137620","doi-asserted-by":"crossref","unstructured":"Peng J, Wang Q, Mei H, Zheng H, Liang G, She X, et al. Fungal co-infection in COVID-19 patients: Evidence from a systematic review and meta-analysis. Aging (Albany, NY). 2021;13:7745-57. https:\/\/doi.org\/10.18632\/aging.202742","DOI":"10.18632\/aging.202742"},{"key":"137621","doi-asserted-by":"crossref","unstructured":"Hoenigl M, Seidel D, Sprute R, Cunha C, Oliverio M, Goldman GH, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7:1127-40. https:\/\/doi.org\/10.1038\/s41564-022-01172-2","DOI":"10.1038\/s41564-022-01172-2"},{"key":"137622","doi-asserted-by":"crossref","unstructured":"Soni S, Namdeo-Pudake R, Jain U, Chauhan N. A systematic review on SARS-CoV-2-associated fungal coinfections. J Med Virol. 2022;94:99-109. https:\/\/doi.org\/10.1002\/jmv.27358","DOI":"10.1002\/jmv.27358"},{"key":"137623","doi-asserted-by":"crossref","unstructured":"Pipitone G, Spicola D, Abbott M, Sanfilippo A, Onorato F, Di Lorenzo F, et al. Invasive cryptococcal disease in COVID-19: Systematic review of the literature and analysis. Infez Med. 2023;31:6-12. https:\/\/doi.org\/10.53854\/liim-3101-2","DOI":"10.53854\/liim-3101-2"},{"key":"137624","unstructured":"Antinori S, Galimberti L, Milazzo L, Ridolfo AL. Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia. Infez Med. 2020;28(Suppl.1):S29-36."},{"key":"137625","doi-asserted-by":"crossref","unstructured":"Kuehn BM. Pulmonary fungal infections affect patients with COVID-19. JAMA. 2020;324:2248. https:\/\/doi.org\/10.1001\/jama.2020.22914","DOI":"10.1001\/jama.2020.22914"},{"key":"137626","doi-asserted-by":"crossref","unstructured":"Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS ONE. 2021;16:e0251170. https:\/\/doi.org\/10.1371\/journal.pone.0251170","DOI":"10.1371\/journal.pone.0251170"},{"key":"137627","doi-asserted-by":"crossref","unstructured":"Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020;104:7777-85. https:\/\/doi.org\/10.1007\/s00253-020-10814-6","DOI":"10.1007\/s00253-020-10814-6"},{"key":"137628","doi-asserted-by":"crossref","unstructured":"Prestel C, Anderson E, Forsberg K, Lyman M, de Perio MA, Kuhar D, et al. Candida auris outbreak in a COVID-19 specialty care unit - Florida, July-August 2020. MMWR Morb Mortal Wkly Rep. 2021;70:56-7. https:\/\/doi.org\/10.15585\/mmwr.mm7002e3","DOI":"10.15585\/mmwr.mm7002e3"},{"key":"137629","doi-asserted-by":"crossref","unstructured":"Villanueva-Lozano H, Trevi\u00f1o-Rangel RJ, Gonz\u00e1lez GM, Ram\u00edrez-Elizondo MT, Lara-Medrano R, Alem\u00e1n-Bocanegra MC, et al. Outbreak of Candida auris infection in a COVID-19 hospital in Mexico. Clin Microbiol Infect. 2021;27:813-6. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.030","DOI":"10.1016\/j.cmi.2020.12.030"},{"key":"137630","doi-asserted-by":"crossref","unstructured":"Fr\u00edas-De-Le\u00f3n MG, Pinto-Almaz\u00e1n R, Hern\u00e1ndez-Castro R, Garc\u00eda-Salazar E, Meza-Meneses P, Rodr\u00edguez-Cerdeira C, et al. Epidemiology of systemic mycoses in the COVID-19 pandemic. J Fungi (Basel). 2021;7:556. https:\/\/doi.org\/10.3390\/jof7070556","DOI":"10.3390\/jof7070556"},{"key":"137631","doi-asserted-by":"crossref","unstructured":"Sekaran A, Patil N, Sabhapandit S, Sistla SK, Reddy DN. Rhino-orbito-cerebral mucormycosis: an epidemic in a pandemic. IJID Reg. 2022;2:99-106. https:\/\/doi.org\/10.1016\/j.ijregi.2021.12.009","DOI":"10.1016\/j.ijregi.2021.12.009"},{"key":"137632","doi-asserted-by":"crossref","unstructured":"Seyedjavadi SS, Bagheri P, Nasiri MJ, Razzaghi-Abyaneh M, Goudarzi M. Fungal infection in co-infected patients with COVID-19: An overview of case reports\/case series and systematic review. Front Microbiol. 2022;13:888452. https:\/\/doi.org\/10.3389\/fmicb.2022.888452","DOI":"10.3389\/fmicb.2022.888452"},{"key":"137633","doi-asserted-by":"crossref","unstructured":"Cattaneo L, Buonomo AR, Iacovazzo C, Giaccone A, Scotto R, Viceconte G, et al. Invasive fungal infections in hospitalized patients with COVID-19: A non-intensive care single-centre experience during the first pandemic waves. J Fungi (Basel). 2023;9:86. https:\/\/doi.org\/10.3390\/jof9010086","DOI":"10.3390\/jof9010086"},{"key":"137634","doi-asserted-by":"crossref","unstructured":"Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364. https:\/\/doi.org\/10.1016\/j.jcv.2020.104364","DOI":"10.1016\/j.jcv.2020.104364"},{"key":"137635","doi-asserted-by":"crossref","unstructured":"Kurra N, Woodard PI, Gandrakota N, Gandhi H, Polisetty SR, Ang SP, et al. Opportunistic infections in COVID-19: A systematic review and meta-analysis. Cureus. 2022;14:e23687. https:\/\/doi.org\/10.7759\/cureus.23687","DOI":"10.7759\/cureus.23687"},{"key":"137636","doi-asserted-by":"crossref","unstructured":"Pakzad R, Malekifar P, Shateri Z, Zandi M, Akhavan-Rezayat S, Soleymani M, et al. Worldwide prevalence of microbial agents\u2019 coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis. J Clin Lab Anal. 2022;36:e24151. https:\/\/doi.org\/10.1002\/jcla.24151","DOI":"10.1002\/jcla.24151"},{"key":"137637","doi-asserted-by":"crossref","unstructured":"Soltani S, Zandi M, Faramarzi S, Shahbahrami R, Vali M, Rezayat SA, et al. Worldwide prevalence of fungal coinfections among COVID-19 patients: A comprehensive systematic review and meta-analysis. Osong Public Health Res Perspect. 2022;13:15-23. https:\/\/doi.org\/10.24171\/j.phrp.2021.0293","DOI":"10.24171\/j.phrp.2021.0293"},{"key":"137638","doi-asserted-by":"crossref","unstructured":"Azoulay E, Russell L, van de Louw A, Metaxa V, Bauer P, Povoa P, et al. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med. 2020;46:298-314. https:\/\/doi.org\/10.1007\/s00134-019-05906-5","DOI":"10.1007\/s00134-019-05906-5"},{"key":"137639","doi-asserted-by":"crossref","unstructured":"Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2021;27:9-11. https:\/\/doi.org\/10.1016\/j.cmi.2020.09.025","DOI":"10.1016\/j.cmi.2020.09.025"},{"key":"137640","doi-asserted-by":"crossref","unstructured":"Melhem MS, Bertoletti A, Lucca HR, Silva RB, Meneghin FA, Szeszs MW. Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species. Braz J Microbiol. 2014;44:1257-66. https:\/\/doi.org\/10.1590\/S1517-83822014005000018","DOI":"10.1590\/S1517-83822014005000018"},{"key":"137641","doi-asserted-by":"crossref","unstructured":"Piontelli LE. Aportes morfotaxon\u00f3micos en el g\u00e9nero Aspergillus: claves para las especies ambientales y cl\u00ednicas m\u00e1s comunes. Bol Micol. 2008;23:49-66.","DOI":"10.22370\/bolmicol.2008.23.0.122"},{"key":"137642","unstructured":"Saludness. Hospital Regional de Alta Especialidad de Ixtapaluca. Accessed: March 20, 2023. Available at: https:\/\/his.hraei.gob.mx\/"},{"key":"137643","unstructured":"World Health Organization. WHO COVID-19 dashboard. Accessed: May 31, 2023. Available at: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c"},{"key":"137644","doi-asserted-by":"crossref","unstructured":"Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170:1136-47. https:\/\/doi.org\/10.2353\/ajpath.2007.061088","DOI":"10.2353\/ajpath.2007.061088"},{"key":"137645","doi-asserted-by":"crossref","unstructured":"Milne-Price S, Miazgowicz KL, Munster VJ. The emergence of the Middle East respiratory syndrome coronavirus. Pathog Dis. 2014;71:121-36. https:\/\/doi.org\/10.1111\/2049-632X.12166","DOI":"10.1111\/2049-632X.12166"},{"key":"137646","doi-asserted-by":"crossref","unstructured":"MacIntyre CR, Chughtai AA, Barnes M, Ridda I, Seale H, Toms R, et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09. BMC Infect Dis. 2018;18:637. https:\/\/doi.org\/10.1186\/s12879-018-3548-0","DOI":"10.1186\/s12879-018-3548-0"},{"key":"137647","doi-asserted-by":"crossref","unstructured":"Verweij PE, Rijnders BJA, Br\u00fcggemann RJM, Azoulay E, Bassetti M, Blot S, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46:1524-35. https:\/\/doi.org\/10.1007\/s00134-020-06091-6","DOI":"10.1007\/s00134-020-06091-6"},{"key":"137648","doi-asserted-by":"crossref","unstructured":"Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of respiratory viral and fungal coinfections. Clin Microbiol Rev. 2022;35:e0009421. https:\/\/doi.org\/10.1128\/CMR.00094-21","DOI":"10.1128\/CMR.00094-21"},{"key":"137649","doi-asserted-by":"crossref","unstructured":"Park SY, Lim C, Lee SO, Choi SH, Kim YS, Woo JH, et al. Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value. J Infect. 2011;63:447-56. https:\/\/doi.org\/10.1016\/j.jinf.2011.08.007","DOI":"10.1016\/j.jinf.2011.08.007"},{"key":"137650","doi-asserted-by":"crossref","unstructured":"Roman-Montes CM, Bojorges-Aguilar S, Corral-Herrera EA, Rangel-Cordero A, D\u00edaz-Lomel\u00ed P, Cervantes-S\u00e1nchez A, et al. Fungal infections in the ICU during the COVID-19 pandemic in Mexico. J Fungi (Basel). 2023;9:583. https:\/\/doi.org\/10.3390\/jof9050583","DOI":"10.3390\/jof9050583"},{"key":"137651","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Vidal C, Sanjuan G, Moreno-Garc\u00eda E, Puerta-Alcalde P, Garc\u00eda-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: A retrospective cohort study. Clin Microbiol Infect. 2021;27:83-8. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.041","DOI":"10.1016\/j.cmi.2020.07.041"},{"key":"137652","doi-asserted-by":"crossref","unstructured":"Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis. 2005;5:609-22. https:\/\/doi.org\/10.1016\/S1473-3099(05)70238-3","DOI":"10.1016\/S1473-3099(05)70238-3"},{"key":"137653","doi-asserted-by":"crossref","unstructured":"Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. Secondary infections in patients hospitalized with COVID-19: Incidence and predictive factors. Clin Microbiol Infect. 2021;27:451-7. https:\/\/doi.org\/10.1016\/j.cmi.2020.10.021","DOI":"10.1016\/j.cmi.2020.10.021"},{"key":"137654","doi-asserted-by":"crossref","unstructured":"Nebreda-Mayoral T, Miguel-G\u00f3mez MA, March-Rossell\u00f3 GA, Puente-Fuertes L, Cant\u00f3n-Benito E, Mart\u00ednez-Garc\u00eda AM, et al. Bacterial\/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y Le\u00f3n, Spain. Enferm Infecc Microbiol Clin. 2022;40:158-65. https:\/\/doi.org\/10.1016\/j.eimce.2022.02.002","DOI":"10.1016\/j.eimce.2022.02.002"},{"key":"137655","doi-asserted-by":"crossref","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054-62. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"137656","doi-asserted-by":"crossref","unstructured":"Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: A prospectivestudy. Clin Infect Dis. 2021;73:e3606-e3614. https:\/\/doi.org\/10.1093\/cid\/ciaa1065","DOI":"10.1093\/cid\/ciaa1065"},{"key":"137657","doi-asserted-by":"crossref","unstructured":"Rutsaert L, Steinfort N, van Hunsel T, Bomans P, Naesens R, Mertes H, et al. COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020;10:71. https:\/\/doi.org\/10.1186\/s13613-020-00686-4","DOI":"10.1186\/s13613-020-00686-4"},{"key":"137658","doi-asserted-by":"crossref","unstructured":"van de Veerdonk FL, Br\u00fcggemann RJM, Vos S, De Hertogh G, Wauters J, Reijers MHE, et al. COVID-19-associated Aspergillus tracheobronchitis: The interplay between viral tropism, host defense, and fungal invasion. Lancet Respir Med. 2021;9:795-802. https:\/\/doi.org\/10.1016\/S2213-2600(21)00138-7","DOI":"10.1016\/S2213-2600(21)00138-7"},{"key":"137659","doi-asserted-by":"crossref","unstructured":"Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149-62. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1","DOI":"10.1016\/S1473-3099(20)30847-1"},{"key":"137660","doi-asserted-by":"crossref","unstructured":"Li Z, Denning DW. The impact of corticosteroids on the outcome of fungal disease: A systematic review and meta-analysis. Curr Fungal Infect Rep. 2023;17:54-70. https:\/\/doi.org\/10.1007\/s12281-023-00456-2","DOI":"10.1007\/s12281-023-00456-2"},{"key":"137661","doi-asserted-by":"crossref","unstructured":"Mina S, Yaakoub H, Annweiler C, Dub\u00e9e V, Papon N. COVID-19 and fungal infections: A double debacle. Microbes Infect. 2022;24:105039. https:\/\/doi.org\/10.1016\/j.micinf.2022.105039","DOI":"10.1016\/j.micinf.2022.105039"},{"key":"137662","doi-asserted-by":"crossref","unstructured":"Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014;10:95-105. https:\/\/doi.org\/10.2147\/TCRM.S40160","DOI":"10.2147\/TCRM.S40160"},{"key":"137663","doi-asserted-by":"crossref","unstructured":"Arastehfar A, Carvalho A, Nguyen MH, Hedayati MT, Netea MG, Perlin DS, et al. COVID-19-associated candidiasis (CAC): An underestimated complication in the absence of immunological predispositions? J Fungi (Basel). 2020;6:211. https:\/\/doi.org\/10.3390\/jof6040211","DOI":"10.3390\/jof6040211"},{"key":"137664","doi-asserted-by":"crossref","unstructured":"Buil JB, Schouten JA, Wauters J, van de Hoeven H, Verweij PE; CAC-SDD study group. Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination. Intensive Care Med. 2022;48:611-2. https:\/\/doi.org\/10.1007\/s00134-022-06651-y","DOI":"10.1007\/s00134-022-06651-y"},{"key":"137665","doi-asserted-by":"crossref","unstructured":"Kundu R, Singla N. COVID-19 and plethora of fungal infections. Curr Fungal Infect Rep. 2022;16:47-54. https:\/\/doi.org\/10.1007\/s12281-022-00432-2","DOI":"10.1007\/s12281-022-00432-2"},{"key":"137666","doi-asserted-by":"crossref","unstructured":"Crum-Cianflone NF. Invasive aspergillosis associated with severe influenza infections. Open Forum Infect Dis. 2016;3:ofw171 https:\/\/doi.org\/10.1093\/ofid\/ofw171","DOI":"10.1093\/ofid\/ofw171"},{"key":"137667","doi-asserted-by":"crossref","unstructured":"Liu KW, Grau MS, Jones JT, Wang X, Vesely EM, James MR, et al. Postinfluenza environment reduces Aspergillus fumigatus conidium clearance and facilitates invasive aspergillosis in vivo. mBio. 2022;13:e0285422. https:\/\/doi.org\/10.1128\/mbio.02854-22","DOI":"10.1128\/mbio.02854-22"},{"key":"137668","doi-asserted-by":"crossref","unstructured":"Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS ONE. 2011;6:e26050. https:\/\/doi.org\/10.1371\/journal.pone.0026050","DOI":"10.1371\/journal.pone.0026050"},{"key":"137669","doi-asserted-by":"crossref","unstructured":"Shi SJ, Li H, Liu M, Liu YM, Zhou F, Liu B, et al. Mortality prediction to hospitalized patients with influenza pneumonia: PO2 \/FiO2 combined lymphocyte count is the answer. Clin Respir J. 2017;11:352-60. https:\/\/doi.org\/10.1111\/crj.12346","DOI":"10.1111\/crj.12346"},{"key":"137670","doi-asserted-by":"crossref","unstructured":"Feys S, Almyroudi MP, Braspenning R, Lagrou K, Spriet I, Dimopoulos G, et al. A visual and comprehensive review on COVID-19-associated pulmonary aspergillosis (CAPA). J Fungi (Basel). 2021;7:1067. https:\/\/doi.org\/10.3390\/jof7121067","DOI":"10.3390\/jof7121067"},{"key":"137671","doi-asserted-by":"crossref","unstructured":"Castro-Fuentes CA, Reyes-Montes MD, Fr\u00edas-De-Le\u00f3n MG, Valencia-Ledezma OE, Acosta-Altamirano G, Duarte-Escalante E. Aspergillus-SARS-CoV-2 coinfection: What Is known? Pathogens. 2022;11:1227. https:\/\/doi.org\/10.3390\/pathogens11111227","DOI":"10.3390\/pathogens11111227"},{"key":"137672","doi-asserted-by":"crossref","unstructured":"Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: A retrospective study. Intensive Care Med. 2012;38:1761-8. https:\/\/doi.org\/10.1007\/s00134-012-2673-2","DOI":"10.1007\/s00134-012-2673-2"},{"key":"137673","doi-asserted-by":"crossref","unstructured":"Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005. https:\/\/doi.org\/10.1016\/j.virusres.2020.198005","DOI":"10.1016\/j.virusres.2020.198005"},{"key":"137674","doi-asserted-by":"crossref","unstructured":"White PL, Dhillon R, Cordey A, Hughes H, Faggian F, Soni S, et al. A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit. Clin Infect Dis. 2021;73:e1634-44. https:\/\/doi.org\/10.1093\/cid\/ciaa1298","DOI":"10.1093\/cid\/ciaa1298"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7251\/5489","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7251\/5661","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7251\/5489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:13:32Z","timestamp":1773321212000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/7251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":56,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,8,29]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.7251","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"2024-08-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Art\u00edculos originales","name":"content_type","label":"Content Type"}]}}